Effect of myo-inositol and d-chiro-inositol on improving hormonal, metabolic and reproductive parameters in women with polycystic ovary syndrome: A review of studies
Polycystic ovary syndrome (PCOS) is a leading cause of anovulatory infertility, affecting 6–12% of women of reproductive age. It is characterized by hormonal and metabolic disturbances, including insulin resistance, hyperandrogenism, and dyslipidemia, which significantly impair reproductive function...
Saved in:
| Main Authors: | Aleksandra Ciuła, Michał Borawski, Anna Jakubiak, Joanna Miśkiewicz, Tadeusz Kuźnieców, grzegorz Karaban, Patrycja Znamirowska, Klaudia Mularczyk, Magdalena Kupis, Monika Paszkowska |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nicolaus Copernicus University in Toruń
2025-05-01
|
| Series: | Quality in Sport |
| Subjects: | |
| Online Access: | https://apcz.umk.pl/QS/article/view/60350 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial
by: Nicolas Mendoza, et al.
Published: (2019-08-01) -
Impact of Myo-Inositol-Chiro Inositol Combination on the improvement of Polycystic Ovary Syndrome Condition
by: Zuhair Assi Hussein, et al.
Published: (2024-12-01) -
Effectiveness, Tolerability and Safety of a Compound Based on D-chiro-inositol + Myo-inositol, Melatonin, Folic Acid, and Vitamin D in Patients with Menstrual Cycle Disorders
by: Silvia P. González, et al.
Published: (2024-02-01) -
PCOS and Inositols – Advances and Lessons We are Learning. A Narrative Review
by: Lentini G, et al.
Published: (2025-05-01) -
Nonlipid myo-inositol derivatives: preparation and biomedical applications
by: A. E. Stepanov, et al.
Published: (2011-04-01)